1 |
Sugahara T, Sato A, Kudo M, Ben-Menahem D, Pixley MR, Hsueh AJ, Boime I (1996): Expression of biologically active fusion genes encoding the common subunit and the follicle-stimulating hormone subunit. J BioI Chem 271:10445-10448.
DOI
|
2 |
Walsh G (2006): Biopharmaceutical benchmarks. Net Biotechonol 24:769-776.
|
3 |
Wurm FM (2004): Production of recombinant protein therapeutics in cultivated mammalian cells. Nat Biotechnol 22:1393-1398.
DOI
ScienceOn
|
4 |
Zufferey R, Donello JE, Trono D, Hope TJ (1999): Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes by retroviral vectors. J Virol 73:2886-2892.
|
5 |
Montesino R, Garcia R, Quintero O, Cremata JA (1998): Variation in N-linked oligosaccharide structures on heterologous proteins secreted by the methylotrophic yeast Pichia pastoris. Protein Expr Purif 14:197-207.
DOI
ScienceOn
|
6 |
Moyle WR, Myers RV, Wang Y, Han Y, Lin W, Kelley GL, Ehrlich PH, Rao SN, Bernard MP (1998): Functional homodimeric glycoprotein hormones: implications for hormone action and evolution. Chem BioI 5:241-254.
DOI
ScienceOn
|
7 |
Nishikawa M, Huang L (2001): Nonviral vectors in the new millennium: delivery barriers in gene transfer. Hum Gene Ther 12:861-870.
DOI
ScienceOn
|
8 |
Out HJ, Mannaerts BMJL, Driessen SGAJ, Bennink HJTC (1996): Recombinant follicle stimulating hormone (rFSH; Puregon) in assisted reproduction: more oocytes, more pregnancies. Results from five comparative studies. Hum Reprod Update 2:162-71.
DOI
ScienceOn
|
9 |
Out HJ., Bennink HJ, de Laat WN (1999): What are the clinical benefits of recombinant gonadotrphins? the development of recombinant FSH (Puregon): a scientific business. Hum Reprod 14:2189-2190.
DOI
|
10 |
Padmanbhan V, Chappel SC, Beitins IZ (1987): An improved in vitro bioassay for follicle-stimulating hormone (FSH): suitable for measurement of FSH in unextracted human serum. Endocrinol 121:1089-1098.
DOI
ScienceOn
|
11 |
Palomares LA, Estrada MS, Ramirez OT (2004): Production of recombinant protein: Challenges and solutions. Methods Mol BioI 267:15-52.
|
12 |
Pavlou AK, Reichert JM (2004): Recombinant protein therapeutics-success rates, market trends and values to 2010. Nature Biotechnol 22:1513-1519.
DOI
ScienceOn
|
13 |
Kirby SL (1999): The therapeutic potential of erythropoietin receptor transgenes. Cytokines Cell Mol Ther 5:97-104.
|
14 |
Klein J, Lobel L, Pollak S, Lustbader B, Ogden RT, Sauer MV, Lustbader JW (2003): Development and characterization of a long-acting recombinant hFSH agonist. Hum Reprod 18:50-56.
DOI
ScienceOn
|
15 |
Lapolt PS, Nishimori K, Fares FA, Perlas E, Boime I, Hsueh AJW (1992): Enhanced stimulation of follicle maturation and ovulatory potential by long acting follicle-stimulating hormone agonist with extended carboxylterminal peptide. Endocrinol 131:2514-2520.
DOI
ScienceOn
|
16 |
Kay MA, Glorioso JC, Naldini L (2001): Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics. Nature Med 7:33-40.
DOI
ScienceOn
|
17 |
Fares FA, Suganuma N, Nishimori K, LaPolt PS, Hsueh AJ, Boime I (1992): Design of a long-acting follitropin agonist by fusing the C-terminal sequence of the chorionic gonadotropin subunit to the foIIitropin subunit. Proc Natl Acad Sci USA 89:4304-4308.
DOI
ScienceOn
|
18 |
Jennings CJ, Moreland K, Peterson CM (1996): In vitro fertilization. Drugs 52:313-343.
DOI
ScienceOn
|
19 |
Jones HW Jr, Jones GS, Andrews MC, Acosta A, Bundren C, Garcia J, Sandow B, Veeck L, Wilkes C, Witmyer J, Wortham JE, Wright G (1982): The program for in vitro fertilization at Norfolk. Fertil Steril 38:14-21.
|
20 |
Kim MO, Kim SH, Shin MJ, Lee DB, Kim TW, Kim KS, Ha JH, Lee S, Park YB, Kim SJ, Ryoo ZY (2006): Human erythropoietin induces lung failure and erythrocytosis in transgenic mice. Mol Cells 23:17-22.
|
21 |
Kim NS, Chang KH, Chung BS, Kim SH, Kim JH, Lee GM (2003): Characterization of humanized anti-body produced by apoptosis-resistant CHO cells under sodium butyrate-induced condition. J Microbiol Biotechnol 13:926-936.
|
22 |
Kim T (2002): Retrovirus-mediated gene transfer. In Transgenic Animal Technology. Edited by Pinkert CA. 2nd ed. Academic Press, San Diego, CA, pp 173-193.
|
23 |
Speroff L, Glass RH, Kase NG (1989): Clinical Gynecologic Endocrinology and Infertility, pp 583-609. 3rd Ed. Williams & Wikins, Baltimore, USA.
|
24 |
Baenziger JU, Green ED (1988): Pituitary glycoprotein hormone oligosaccharides: Structure, synthesis and function of the asparagine-linked oligosaccharides on lutropin, follitropin and thyrotropin. Biochim Biophys Acta 947:287-306.
DOI
ScienceOn
|
25 |
Bagatti GC, Datola CA, Gostoli G, Mascia M, Polletta P, Roncalli G, Simoni P (2001): Characterization and comparison of recombinant human follicle-stimulating hormones. J Clin Res 4:91-104.
|
26 |
Prevost RR (1998): Recombinant follicle-stimulating hormone: New biotechnology for infertility. Pharmacotherapy 18:1001-1010.
|
27 |
Reichert Jr, LE, Dattatreyamurty B (1989): The follicle-stimulating hormone (FSH) receptor in testis: interaction with FSH, mechanism of signal transduction, and properties of the purified receptor. BioI Reprod 40:13-26.
DOI
ScienceOn
|
28 |
Schaison G, Young J, Pholsena M, Nahoul K, Couzinet B (1993): Failure of combined follicle-stimulating hormone-testosterone administration to initiate and/or maintain spermatogenesis in men with hypogonadotropic hypogonadism. J Clin Endocrinol Metab 77:1545-1549.
DOI
ScienceOn
|
29 |
Liu ML, Winther BL, Kay MA (1996): Pseudotransduction of hepatocytes by using concentrated pseudotyped vesicular stomatitis virus G glycoprotein (VSVG)-Moloney murine leukemia virus-derived retrovirus vectors: comparison of VSV-G and amphotropic vectors for hepatic gene transfer. J Viral 70:2497-2502.
|
30 |
Link N, Aubel C, Kelm JM, Marty RR, Greber D, Djonov V, Bourhis J, Weber W, Fussenegger M (2006): Therapeutic protein transduction of mammalian cells and mice by nucleic acid-free lentiviral nanoparticles. Nucleic Acids Res 34:e16.
DOI
ScienceOn
|
31 |
Loumaye E, Campbell R, Salat-Baroux J (1995): Human follicle-stimulating hormone produced by recombinant DNA technology: a review for clinicians. Hum Reprod Update 1:188-199.
DOI
ScienceOn
|
32 |
Chung JY, Ahn HK, Lim SW, Sung YH, Koh YW, Park SK, Lee GM (2003): Development of recombinant Chinese hamster ovary cell lines producing human thrombopoietin or its analog. J Microbiol Biotechnol 13:759-766.
|
33 |
Chang GD, Chen CJ, Lin CY, Chen HC, Chen H (2003): Improvement of glycosylation in insect cells with mammalian glycosyltransferases. J Biotechnol 102:61-71.
DOI
ScienceOn
|
34 |
Bergh C, Howles CM, Borg K, Hamberger L, Josefsson B, Nilsson L, Wikland M (1997): Recombinant human follicle stimulating hormone (r-hFSH; Gonal-F) versus highly purified urinary FSH (Metrodin HP): results of a randomized comparative study in women undergoing assisted reproductive techniques. Hum Reprod 12:2133-2139.
DOI
ScienceOn
|
35 |
Braun P, LaBaer J (2003): High throughput protein production for functional proteomics. Trends biotechnol 21:383-388.
DOI
ScienceOn
|
36 |
Burns JC, Friedmann T, Driever W, Burrascano M, Yee JK (1993): Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: Concentration to very high titer and effcient gene transfer into mammalian and nonmammalian cells. Proc Natl Acad Sci USA 90:8033-8037.
DOI
ScienceOn
|